These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11956611)

  • 41. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
    Marttunen MB; Hietanen P; Tiitinen A; Ylikorkala O
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials.
    Zhou WB; Ding Q; Chen L; Liu XA; Wang S
    Breast Cancer Res Treat; 2011 Aug; 128(3):625-31. PubMed ID: 21553116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adverse outcome and resistance to adjuvant antiestrogen therapy in node-positive postmenopausal breast cancer patients-The role of p53.
    Rahko E; Blanco G; Bloigu R; Soini Y; Talvensaari-Mattila A; Jukkola A
    Breast; 2006 Feb; 15(1):69-75. PubMed ID: 16005229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Adjuvant chemotherapy of gastric cancer].
    Shparik IaV
    Klin Khir; 1995; (5):38-41. PubMed ID: 8646632
    [No Abstract]   [Full Text] [Related]  

  • 45. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.
    Karlsson YA; Malmström PO; Hatschek T; Fornander TG; Söderberg M; Bengtsson NO; Jansson TE; Sjöberg SM; Bergh JC
    Cancer; 1998 Sep; 83(5):936-47. PubMed ID: 9731898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
    Fisher B; Jeong JH; Bryant J; Anderson S; Dignam J; Fisher ER; Wolmark N;
    Lancet; 2004 Sep 4-10; 364(9437):858-68. PubMed ID: 15351193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
    ; Colleoni M; Gelber S; Goldhirsch A; Aebi S; Castiglione-Gertsch M; Price KN; Coates AS; Gelber RD
    J Clin Oncol; 2006 Mar; 24(9):1332-41. PubMed ID: 16505417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.
    Martelli G; Miceli R; Costa A; Coradini D; Zurrida S; Piromalli D; Vetrella G; Greco M
    Cancer; 2008 Feb; 112(3):481-8. PubMed ID: 18098268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of metastatic breast cancer resistant to anastrozole treatment responding to high-dose toremifene].
    Murata T; Yoshino H; Bandou H; Morita K; Kurokawa M; Inaki N; Kotake M; Kadoya S; Yamamoto M; Takayanagi T; Yamada T
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):671-3. PubMed ID: 19381046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Toremifene on Endometrium and Neurocognitive Function in Patients with Breast Cancer Based on Resting-State Functional Magnetic Resonance Imaging.
    Zhou Y; Fan Y; Ma L; Nowen J
    World Neurosurg; 2021 May; 149():436-443. PubMed ID: 33217593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synchronous cancer and metastatic melanoma of the breasts.
    Komorowski AL; Wysocki WM; Mituś J
    Arch Gynecol Obstet; 2004 Dec; 270(4):290-1. PubMed ID: 14551797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nutritional folate status influences the efficacy and toxicity of chemotherapy in rats.
    Branda RF; Nigels E; Lafayette AR; Hacker M
    Blood; 1998 Oct; 92(7):2471-6. PubMed ID: 9746787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of cancer with cytostatics: results with high dose therapy with cyclophosphamide and drug targeting with doxorubicin].
    Busse D; Kroemer HK; Sperker B; Mürdter TE
    Pharm Unserer Zeit; 1998 Sep; 27(5):216-22. PubMed ID: 9800467
    [No Abstract]   [Full Text] [Related]  

  • 55. Leukemic mastopathy.
    Schalk E; Heidel FH
    Int J Hematol; 2016 Apr; 103(4):357-8. PubMed ID: 26857154
    [No Abstract]   [Full Text] [Related]  

  • 56. Comment on the article "Outcome of surgically treated octogenarians with breast cancer".
    Belli AK; Memis G; Dere O; Nazli O
    J Postgrad Med; 2015; 61(2):144. PubMed ID: 25766358
    [No Abstract]   [Full Text] [Related]  

  • 57. Summary of clinical data on antitumor antibiotics in Japan.
    Koyama Y
    Recent Results Cancer Res; 1978; 63():1-19. PubMed ID: 360329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bilateral simultaneous breast cancer.
    CARROLL WW; SHIELDS TW
    AMA Arch Surg; 1955 May; 70(5):672-9. PubMed ID: 14360997
    [No Abstract]   [Full Text] [Related]  

  • 59. [Bilateral cancer of the breast].
    KIRSCH J
    Paris Med; 1951 May 12-19; 41(18-19):267-8. PubMed ID: 14853579
    [No Abstract]   [Full Text] [Related]  

  • 60. [Bilateral cancer of the breast].
    MONTORO AF
    Rev Paul Med; 1961 Nov; 59():319-26. PubMed ID: 14475576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.